A randomized, double-blind trial comparing the effect of two blood pressure targets on global brain metabolism after out-of-hospital cardiac arrest

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 4,62 MB, PDF-dokument

Purpose
This study aimed to assess the effect of different blood pressure levels on global cerebral metabolism in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA).

Methods
In a double-blinded trial, we randomly assigned 60 comatose patients following OHCA to low (63 mmHg) or high (77 mmHg) mean arterial blood pressure (MAP). The trial was a sub-study in the Blood Pressure and Oxygenation Targets after Out-of-Hospital Cardiac Arrest-trial (BOX). Global cerebral metabolism utilizing jugular bulb microdialysis (JBM) and cerebral oxygenation (rSO2) was monitored continuously for 96 h. The lactate-to-pyruvate (LP) ratio is a marker of cellular redox status and increases during deficient oxygen delivery (ischemia, hypoxia) and mitochondrial dysfunction. The primary outcome was to compare time-averaged means of cerebral energy metabolites between MAP groups during post-resuscitation care. Secondary outcomes included metabolic patterns of cerebral ischemia, rSO2, plasma neuron-specific enolase level at 48 h and neurological outcome at hospital discharge (cerebral performance category).

Results
We found a clear separation in MAP between the groups (15 mmHg, p < 0.001). Cerebral biochemical variables were not significantly different between MAP groups (LPR low MAP 19 (16–31) vs. high MAP 23 (16–33), p = 0.64). However, the LP ratio remained high (> 16) in both groups during the first 30 h. During the first 24 h, cerebral lactate > 2.5 mM, pyruvate levels > 110 µM, LP ratio > 30, and glycerol > 260 µM were highly predictive for poor neurological outcome and death with AUC 0.80. The median (IQR) rSO2 during the first 48 h was 69.5% (62.0–75.0%) in the low MAP group and 69.0% (61.3–75.5%) in the high MAP group, p = 0.16.

Conclusions
Among comatose patients resuscitated from OHCA, targeting a higher MAP 180 min after ROSC did not significantly improve cerebral energy metabolism within 96 h of post-resuscitation care. Patients with a poor clinical outcome exhibited significantly worse biochemical patterns, probably illustrating that insufficient tissue oxygenation and recirculation during the initial hours after ROSC were essential factors determining neurological outcome.
OriginalsprogEngelsk
Artikelnummer73
TidsskriftCritical Care
Vol/bind27
Udgave nummer1
Antal sider13
ISSN1364-8535
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
We thank the critical care healthcare professionals at the Department of Anesthesiology and Intensive Care, Odense University Hospital, who each and collectively made this study possible. Among comatose patients resuscitated from OHCA, targeting a higher MAP 180 min after ROSC did not significantly improve cerebral energy metabolism and oxygenation. Initial cerebral reperfusion in most patients is insufficient to restore cerebral energy metabolism, potentially influencing neurological outcomes. Targeting a higher MAP 180 min after ROSC did not significantly improve cerebral energy metabolism among comatose patients resuscitated from cardiac arrest.

Funding Information:
This study was sponsored by non-profit organizations, including the University of Southern Denmark, Region of Southern Denmark, and the Department of Anesthesiology and Intensive Care, Odense. Moreover, the study received independent grants from A.P. Moeller Foundation for the Advancement of Medical Science; Intensive Symposium Hindsgavl; Danish Society of Anesthesiology & Intensive Care Medicine; The Board of Physicians’ Legacy Committee, Odense University Hospital. The funding organizations did not affect the trial’s design, administration, or reporting.

Publisher Copyright:
© 2023, The Author(s).

ID: 363554353